Clinical Trials In Seattle

Discover hundreds of clinical trials in Seattle.
Search clinical trials in Seattle by condition or phase.

e.g. Respiratory Diseases

Seattle•Healthy volunteers: No

Filter results

Results: 1,494

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Recruiting

Sponsor:

NRG Oncology

Location:

Seattle, Yelm, Walla Walla, Silverdaleshow 358 more

Code:

NCT05896189

Conditions

Breast Cancer

Cognitive Impairments

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Arm 1: Computerized Cognitive Training-Global Stimulation Games

Arm 2: Computerized Cognitive Training-Neuroplasticity Games

A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer

Recruiting

Phase 2

Sponsor:

Hoffmann-La Roche

Location:

Seattle, Birmingham, Orlando, Clevelandshow 4 more

Code:

NCT05645692

Conditions

Urothelial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Atezolizumab

Tobemstomig

Tiragolumab

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Recruiting

Phase 1

Sponsor:

Fred Hutchinson Cancer Center

Location:

Seattle

Code:

NCT04375631

Conditions

Recurrent Acute Myeloid Leukemia

Recurrent Chronic Myelomonocytic Leukemia

Recurrent Myelodysplastic Syndrome

Refractory Acute Myeloid Leukemia

Refractory Chronic Myelomonocytic Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cladribine

Cyclophosphamide

Cyclosporine

Cytarabine

Filgrastim

Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer

Recruiting

Phase 1

Phase 2

Sponsor:

Verastem, Inc.

Location:

Seattle, San Francisco, Chicago, Bostonshow 5 more

Code:

NCT05669482

Conditions

KRAS Activating Mutation

Metastatic Cancer

Pancreas Cancer

Neoplasms Pancreatic

Malignant Neoplasm of Pancreas

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel

A Study of Subcutaneous Blinatumomab Administration in Acute Lymphoblastic Leukemia (ALL) Patients

Recruiting

Phase 1

Phase 2

Sponsor:

Amgen

Location:

Seattle, Duarte, New York, Houston

Code:

NCT04521231

Conditions

B Cell Precursor Acute Lymphoblastic Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Blinatumomab

Pediatric Lumbar Puncture Success Using the COMPASS

Recruiting

Sponsor:

Seattle Children's Hospital

Location:

Seattle

Code:

NCT01285531

Conditions

Lumbar Puncture

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Interventions

Compass Lumbar Puncture Enhanced

RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.

Recruiting

Sponsor:

Ablacon, Inc.

Location:

Bellevue, Phoenix, Redwood City, Santa Monicashow 7 more

Code:

NCT05883631

Conditions

Atrial Fibrillation

Atrial Fibrillation, Persistent

Atrial Fibrillation Paroxysmal

Arrhythmia

Arrhythmias, Cardiac

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

EGF-Mapping and EGF-Guided Ablation of AF Sources

EGF-Mapping of AF Sources (no ablation)

Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

Recruiting

Sponsor:

Glaukos Corporation

Location:

Seattle, Palo Alto, Bloomington, Bozemanshow 7 more

Code:

NCT03319082

Conditions

Corneal Ectasia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Corneal Collagen Cross-linking

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Recruiting

Phase 3

Sponsor:

Stealth BioTherapeutics Inc.

Location:

Silverdale, Phoenix, Sun City, Huntington Beachshow 29 more

Code:

NCT06373731

Conditions

Age Related Macular Degeneration (ARMD)

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

Elamipretide

Placebo

MEASuRE: Metreleptin Effectiveness And Safety Registry

Recruiting

Sponsor:

Aegerion Pharmaceuticals, Inc.

Location:

Seattle, Birmingham, Duarte, Atlantashow 10 more

Code:

NCT02325674

Conditions

Generalised Lipodystrophy

Partial Lipodystrophy

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Metreleptin

e.g. Respiratory Diseases

Seattle•Healthy volunteers: No

Filter results

Results: 1,494

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Recruiting

Sponsor:

NRG Oncology

Location:

Seattle, Yelm, Walla Walla, Silverdaleshow 358 more

Code:

NCT05896189

Conditions

Breast Cancer

Cognitive Impairments

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Arm 1: Computerized Cognitive Training-Global Stimulation Games

Arm 2: Computerized Cognitive Training-Neuroplasticity Games

A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer

Recruiting

Phase 2

Sponsor:

Hoffmann-La Roche

Location:

Seattle, Birmingham, Orlando, Clevelandshow 4 more

Code:

NCT05645692

Conditions

Urothelial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Atezolizumab

Tobemstomig

Tiragolumab

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Recruiting

Phase 1

Sponsor:

Fred Hutchinson Cancer Center

Location:

Seattle

Code:

NCT04375631

Conditions

Recurrent Acute Myeloid Leukemia

Recurrent Chronic Myelomonocytic Leukemia

Recurrent Myelodysplastic Syndrome

Refractory Acute Myeloid Leukemia

Refractory Chronic Myelomonocytic Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cladribine

Cyclophosphamide

Cyclosporine

Cytarabine

Filgrastim

Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer

Recruiting

Phase 1

Phase 2

Sponsor:

Verastem, Inc.

Location:

Seattle, San Francisco, Chicago, Bostonshow 5 more

Code:

NCT05669482

Conditions

KRAS Activating Mutation

Metastatic Cancer

Pancreas Cancer

Neoplasms Pancreatic

Malignant Neoplasm of Pancreas

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel

A Study of Subcutaneous Blinatumomab Administration in Acute Lymphoblastic Leukemia (ALL) Patients

Recruiting

Phase 1

Phase 2

Sponsor:

Amgen

Location:

Seattle, Duarte, New York, Houston

Code:

NCT04521231

Conditions

B Cell Precursor Acute Lymphoblastic Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Blinatumomab

Pediatric Lumbar Puncture Success Using the COMPASS

Recruiting

Sponsor:

Seattle Children's Hospital

Location:

Seattle

Code:

NCT01285531

Conditions

Lumbar Puncture

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Interventions

Compass Lumbar Puncture Enhanced

RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.

Recruiting

Sponsor:

Ablacon, Inc.

Location:

Bellevue, Phoenix, Redwood City, Santa Monicashow 7 more

Code:

NCT05883631

Conditions

Atrial Fibrillation

Atrial Fibrillation, Persistent

Atrial Fibrillation Paroxysmal

Arrhythmia

Arrhythmias, Cardiac

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

EGF-Mapping and EGF-Guided Ablation of AF Sources

EGF-Mapping of AF Sources (no ablation)

Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

Recruiting

Sponsor:

Glaukos Corporation

Location:

Seattle, Palo Alto, Bloomington, Bozemanshow 7 more

Code:

NCT03319082

Conditions

Corneal Ectasia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Corneal Collagen Cross-linking

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Recruiting

Phase 3

Sponsor:

Stealth BioTherapeutics Inc.

Location:

Silverdale, Phoenix, Sun City, Huntington Beachshow 29 more

Code:

NCT06373731

Conditions

Age Related Macular Degeneration (ARMD)

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

Elamipretide

Placebo

MEASuRE: Metreleptin Effectiveness And Safety Registry

Recruiting

Sponsor:

Aegerion Pharmaceuticals, Inc.

Location:

Seattle, Birmingham, Duarte, Atlantashow 10 more

Code:

NCT02325674

Conditions

Generalised Lipodystrophy

Partial Lipodystrophy

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Metreleptin